Crystal Structure Analysis of the Polysialic Acid Specific O-Acetyltransferase NeuO

The major virulence factor of the neuroinvasive pathogen Escherichia coli K1 is the K1 capsule composed of α2,8-linked polysialic acid (polySia). K1 strains harboring the CUS-3 prophage modify their capsular polysaccharide by phase-variable O-acetlyation, a step that is associated with increased virulence. Here we present the crystal structure of the prophage-encoded polysialate O-acetyltransferase NeuO. The homotrimeric enzyme belongs to the left-handed β-helix (LβH) family of acyltransferases and is characterized by an unusual funnel-shaped outline. Comparison with other members of the LβH family allowed the identification of active site residues and proposal of a catalytic mechanism and highlighted structural characteristics of polySia specific O-acetyltransferases. As a unique feature of NeuO, the enzymatic activity linearly increases with the length of the N-terminal poly-ψ-domain which is composed of a variable number of tandem copies of an RLKTQDS heptad. Since the poly-ψ-domain was not resolved in the crystal structure it is assumed to be unfolded in the apo-enyzme.


Introduction
Extra-intestinal pathogenic Escherichia coli (ExPEC) strains of the capsular serotype K1 are the predominant cause of neonatal sepsis and meningitis [1,2]. The major virulence factor of Escherichia coli K1 (E. coli K1) is the K1 capsule which is essential for serum resistance and vital passage through the blood brain barrier [1,3]. The capsular polysaccharide (cps) consists of a2,8linked polysialic acid (polySia), a polyanionic homopolymer composed of up to 200 residues of the sialic acid 5-N-acetyl neuraminic acid (Neu5Ac) [4]. Structurally identical polySia is found in the host organism, where it occurs as a functionally important glycan modification of the neural cell adhesion molecule, NCAM, involved in brain development and synaptic plasticity [5,6]. Thus, E. coli K1 disguises itself with a host sugar polymer which limits immunodetection and raises concerns against polySia-based vaccines [7,8]. The same mechanism of molecular mimicry is used by Neisseria meningitidis (N. meningitidis or meningococcus) serogroup B, an important cause of sepsis and meningitis after the neonatal period. However, whereas a2,8linked polySia of both group B menigococci and the human host consists exclusively of Neu5Ac residues, the polySia capsule of many E. coli K1 strains can be modified by O-acetylation of the Neu5Ac residues at positions O 7 and O 9 [9][10][11]. Although Oacetylation increases immunogenicity of the K1 capsule it was correlated with increased virulence rates in bacteraemic patients [12]. Moreover, O-acetylation impairs polySia degradation by neuraminidases and increases desiccation resistance, which may favour colonization of the intestinal tract and survival outside the host organism, respectively [11,13].
O-acetylation of the E. coli K1 capsule is catalyzed by the acetyl-CoA dependent sialate O-acetyltransferase NeuO, an enzyme that is highly specific for a2,8-linked polySia with a minimum chain length of 14 residues [10,14]. The corresponding gene is not part of the cps gene cluster but is associated with the P22-like prophage CUS-3 [9,15]. As a result, only K1 strains harbouring CUS-3 are able to O-acetylate their capsule and the presence of CUS-3/neuO is tightly linked to K1 strains of the phylogenetic sequence type complex 95 comprising human invasive isolates [13].
Notably, K1 capsule O-acetylation (OAc) undergoes highfrequency phase-variation [11]. This stochastic switch between 'on' (OAc + ) and 'off' (OAc 2 ) forms is mediated by a variable number tandem repeat (VNTR) within the 59-coding region of neuO [9]. The VNTR region, denoted poly-y-motif, is inserted two nucleotides downstream of the start codon and consists of the heptanucleotide unit 59-AAGACTC-39 which occurs in copy numbers between 2 and 93 [9,13]. During replication, this region is prone to strand slippage leading to frequent changes in overall length, with gain or loss of a single tandem copy being the most frequent event [16]. Full length translation and thereby expression of active NeuO (phase 'on') is restricted to copy numbers that are a multiple of three, whereas all other copy numbers result in frameshifts leading to truncated, inactive protein (phase 'off') [9]. In the case of full length translation, every three tandem repeats are translated into an RLKTQDS heptad. Although this variable N-terminal protein extension is not a prerequisite for activity, the catalytic efficiency increases linearly with the number of RLKTQDS heptads, representing a unique mechanism for gradual regulation of enzymatic activity [9,14].
Beyond the variable poly-y-domain, NeuO is characterized by the presence of imperfect tandem repeats of the hexapeptide motif [LIV]-[GAED]-X 2 -[STAV]-X, a hallmark of the hexapeptide repeat family of acyltransferases [17]. The crystal structures of several members of this family reveal that three hexapeptides fold into one coil of a left-handed parallel b-helix (LbH), which resembles a triangular prism [18,19]. Based on this central fold, the family is also termed LbH-superfamily and comprises not only acyltransferases but also Zn-dependent c-carbonic anhydrases [20].
In the present study, we crystallized NeuO using a protein variant with four N-terminal RLKTQDS heptads. The crystal structure shows that NeuO is a member of the LbH-family that displays an unusual quaternary structure arrangement presumably as an adaptation to accommodate the exceptionally long polySia acceptor. Comparison between the structures of NeuO and OatWY revealed highly conserved residues within the active site allowing to propose a catalytic mechanism for NeuO.

Structure determination
For structure determination of NeuO, the protein variant with four N-terminal RLKTQDS heptads was chosen. Initially, the protein was expressed from the naturally occurring allele neuO +12 which contains twelve tandem copies of the heptanucleotide unit 59-AAGACTC-39 encoding four RLKTQDS heptads. However, no crystals were obtained for protein expressed from this VNTR containing sequence. Since VNTRs are prone to slipped-strand DNA synthesis, neuO variants with altered repeat numbers can be generated when bacteria are grown for protein expression. Eventually, this may lead to trace amounts of protein with three and/or five N-terminal heptads. To omit the formation of heterogeneous protein, we engineered a neuO gene in which the VNTR-region was replaced by an artificial sequence stretch that still encoded four RLKTQDS heptads but lacked any nucleotide repeats ( Figure 1). Protein expressed from this engineered sequence had a total length of 252 residues including a C-terminal His 6 -tag. Throughout the manuscript, the numbering of amino acid residues was performed with the N-terminal residue (methionine) numbered 1. Accordingly, the numbering of residues located C-terminally to the four heptads increased by 28 compared to a NeuO variant devoid of RLKTQDS heptad repeats.
Protein expressed from the engineered sequence yielded crystals that belong to space group P2 1 . The crystals contain three monomers in the asymmetric unit and diffract up to a resolution of 1.7 Å ( Table 1). Phases were obtained by molecular replacement. The NeuO structure was refined to R-factors of 16.6% (R free = 19.5%) and shows good stereochemistry ( Figure S1). In the longest chain that could be placed into the electron density, residues 19-251 are present. By contrast, residues 1-18 encompassing the first two heptads were too flexible to be determined as indicated by increasing B-factors at all three N-termini.

Overall structure
The crystal structure showed that NeuO is a homotrimeric protein with a funnel-like outline ( Figure 2A). The overall shape is a result of the subunit arrangement characterized by an inclination of about 45u between the long axes of the monomers. While the Ntermini point away from each other, giving rise to a diameter of about 65 Å , the monomers interconnect at their C-terminal section leading to a reduced diameter of about 50 Å . Each monomer forms a left-handed parallel b-helix consisting of 23 bstrands forming seven b-helical coils. At half of the length of each monomer the parallel b-helix is interrupted by a protruding loop composed of 20 residues (residues 143-163) including those forming b16. At the C-terminal end, the LbH-domain is extended by a further b-strand and a single a-helix ( Figure 2B). Each trimerization interface is formed by the protruding loop of one subunit interacting with the bar-like ending (b25 and a1) of the adjacent subunit. Notably, intersubunit contacts are mainly formed by the anti-parallel alignment of b16 and b25.

The LbH-domain
The predominant part of the NeuO monomer folds into an LbH-domain. However, in contrast to the canonical LbH fold, which resembles an equilateral triangular prism [18], the LbH domain of NeuO displays a more extended outline. The diameter of the parallel b-helix decreases from 27 Å at the N-terminus to about 10 Å at the C-terminus, resulting in a wedge-like shape of each monomer ( Figure 2B). The distance between the opposing b-strands stays constantly 11.5 Å , which, in combination with the extended outline gives rise to a bean-shaped cross section of the LbH-domain ( Figure 2A, bottom panel). Due to the inclination between the subunits, direct interactions between adjacent LbHdomains are limited to the last two b-rungs (residues 190-210), to the protruding loop and the bar-like C-terminal extension of the LbH-domain. Here the anti-parallel alignment of b-strands b16 and b25 forms hydrogen bonds between the main-chains, which closely connect the individual monomers. With the exception of a salt bridge between chain A and B (Arg174A : Glu119B), which can not be detected between the other chains, intersubunit interactions mediated by the b-rungs are restricted to Asn209 contacting Gly193 and Asn209 of the adjacent chain.

Substrate binding sites
Despite close intersubunit interactions at the bottom of the trimer, a tunnel can be observed between each subunit. These tunnels, about 10 Å in diameter and about 25 Å long, pierce through the enzyme parallel to the long axis of the LbH-domain ( Figure 3). Situated at the N-terminal outlet of each tunnel are His147 and Trp171 (corresponding to His119 and Trp143 in NeuO lacking N-terminal heptad-repeats), which have previously been reported to be catalytically important ( Figure 3B) [14]. Structural similarity to other O-acetyltransferases of the LbHfamily suggests that each tunnel forms a binding site for the donorsubstrate acetyl-CoA. However, since NeuO failed to crystallize in the presence of acetyl-CoA structural evidence is missing. In order to test whether this site can harbor the donor substrate, an acetyl-CoA molecule was successfully modeled into the tunnel by superposition with the crystal structure of O-acetyltransferase OatWY of N. meningitidis serogroup W-135 and Y ( Figure 3) [25].
In conclusion, presence of catalytically important residues in combination with possible donor-substrate binding, indicate that the N-terminal outlet of the observed tunnel represents the active site of NeuO.
In front of the active site, the wide inclination of the three NeuO monomers generates a platform, which is oriented perpendicular to the long axis of the donor-substrate binding tunnel ( Figure 3A). This platform is almost exclusively positively charged ( Figure 2C) and thus well suited to bind the polyanionic substrate polySia. Previous reports have shown that the minimum substrate length for NeuO is a Sia 14 -molecule [10,14], suggesting an extended carbohydrate binding site. The location of positively charged residues around the active site of NeuO (Arg111, Arg234, Lys233, Arg222, Arg174, Arg137, Lys95, and Arg73) (Fig. 3A) implicates that polySia may bind along the positively charged platform, makes a sharp turn behind the active site and then further runs along the inner surface of the LbH domain towards the Nterminus of NeuO. However, co-crystallization trials with colominic acid, partially hydrolyzed polySia containing oligomers with 2 to over 60 residues, did not yield any suitable crystals, most likely due to lack of homogeneity in oligomer length. Using a defined acceptor-substrate was not feasible, since separation capacities of available chromatographic methods to isolate Sia oligomers from hydrolyzed polySia decrease with oligomer length. Accordingly, the longest commercially available substrate is currently Sia 6 and quantity as well as homogeneity of the Sia 14chains separated on an anion-exchange column were not sufficient for co-crystallization experiments.
Previously, it was shown that the catalytic efficiency of NeuO increases linearly with the number of N-terminal heptads [14]. However, since the poly-y-domain is not visible in the electron density of the crystal structure it can be concluded that it is disordered in the apo-enzyme ( Figure S2).

Structural comparison between NeuO and OatWY
Comparison with other members of the LbH-family revealed that the sialate O-acetyltransferase OatWY of serogroup W-135 and Y meningococci [25] is the closest structural homologue of NeuO. The individual monomers can be superimposed with a root-mean-square distance (r.m.s.d) of 0.91080 Å ( Figure 4). Moreover, the quaternary structure of both enzymes is characterized by a tilted arrangement of the subunits with an inclination between the long axes of the monomers of 45u and 34u in NeuO and OatWY, respectively. Within the active sites of NeuO and OatWY, six amino acid residues are highly conserved (see boxed residues in Figures 3A  and 3B). In addition to the catalytically important residues His147 (His121 in OatWY) and Trp171 (Trp145 in OatWY), these include Met134 (Met108 in OatWY), Arg174 (Arg148 in OatWY), Trp220 (Trp195 in OatWY), and Arg222 (Arg197 in OatWY). In both enzymes, Trp220/195 forms a hydrophobic pocket in front of the active site which could be important for trapping the sialic acid moiety currently positioned in the active site in the right orientation. Such a binding mode is found in sialidases which posses a hydrophobic pocket in the active site to accommodate the N-acetyl group of sialic acid [26,27]. Met134/ 108 located next to Trp220/195 could contribute to the hydrophobic pocket but in addition, this residue has a prominent position within the catalytic center of both NeuO and OatWY, pointing towards the active site residues His147/121 and Trp171/ 145.
Arg222/197 positioned in the loop between a1 and b25 (residues 221-232 in NeuO) forms a polar contact with Thr113/ 87 located in the LbH-domain of the same subunit, thereby stabilizing the orientation of this loop. Moreover, the main chain carbonyl oxygen of Arg222/197 is in hydrogen bond distance (2.84 Å ) to the catalytic residue His147/121 from the adjacent subunit and might be relevant for the proper positioning of the catalytic histidine.
As mentioned above, Arg174 forms an intersubunit salt bridge with Glu119 at one out of three interfaces in NeuO. In OatWY, however, this salt bridge is found symmetrically at all three interfaces and is formed by the corresponding residues Arg148 and Glu92. This salt bridge could be relevant for the correct quaternary structure of both enzymes and might be broken up at two interfaces of NeuO only due to the crystalline environment.
Outside of the catalytic center, only one of the positively charged residues forming the proposed polySia binding site of NeuO is conserved in OatWY: Arg111 at the entrance of the positively charged platform, which corresponds to Lys85 in OatWY. This might reflect the differences in acceptor substrate specificities of the two enzymes.

Discussion
In this study, we have solved the structure of the prophageencoded O-acetyltransferase NeuO responsible for phase-variable capsule modification of the neuroinvasive pathogen E. coli K1. The homotrimeric enzyme shares typical features of the LbH-family of acyltransferases combined with an unusual funnel-shaped outline. To highlight structural characteristics of polySia-specific LbHacetyltransferases, the structure of NeuO was compared with other members of the LbH-family. The closest structural homologue of NeuO was found to be the recently crystallized sialate Oacetyltransferase OatWY of N. meningitidis serogroup W-135 and Y [25]. OatWY is specific for the glucose and galactose containing sialic acid heteropolymers [-6-Glc-a1,4-Neu5Ac-a2-] n and [-6-Gal-a1,4-Neu5Ac-a2-} n ], respectively, and catalyzes the transfer of O-acetyl groups from acetyl-CoA to O7 and O9 of the sialic acid moieties. Notably, both NeuO and OatWY differ markedly from other members of the LbH-family with respect to the geometry of the LbH-domain and the orientation of the three subunits. Whereas the common LbH-fold has an equilateral, triangular cross-section [18], this geometry is distorted in NeuO and OatWY and a bean shaped cross-section is observed. Moreover, the parallel arrangement of the individual monomers is lost and the monomers are arranged with a notable inclination of 45u and 34u between each chain in NeuO and OatWY, respectively [25]. Although the acceptor substrates of both enzymes differ in composition and glycosidic linkage of the Neu5Ac residues, both are large polymers. Comparison of LbH-acetyltransferases with regard to their acceptor substrates suggests a correlation between tilted subunit arrangement and substrate size. While the subunits of acetyltransferases with small substrates, like the galactoside acetyltransferase GAT of E. coli are oriented in parallel to each other [28], a more opened subunit orientation is observed in enzymes with bulkier substrates such as the streptogramin acetyltransferase Vat(D) of Enterococcus faecium ( Figure 5) [29]. However, the by far most pronounced inclination between the subunits is found in NeuO and OatWY, apparently in order to accommodate their particularly long polysaccharide substrates.
Interestingly, both NeuO and OatWY share a methionine residue (Met134 and Met108 in NeuO and OatWY, respectively) which occupies a prominent position in the catalytic center. Examination of related structures reveals that a similarly positioned methionine is only found in LbH acetyltransferases that act on di-or oligosaccharides, such as the maltose Oacetyltransferase of E. coli (MAT -Met100) and the galactoside acetyltransferase of E. coli (GAT -Met127) [28]. For none of these enzymes structures containing the respective natural acceptor oligosaccharide are available. However, in the structure of GAT in complex with the non-physiological acceptor substrate p-nitrophe- nyl-b-D-galactopyranoside (PNPbGal) the sulfur of Met127 points towards the oxygen forming the ether bond between PNP and galactose (PDB-ID: 1KVR), suggesting that a non-canonical type of electrostatic interaction may coordinate this bond. Non-bonded interactions between a divalent sulfur (S) and an oxygen (O) atom have been described previously [30,31] and a respective analysis carried out for protein-ligand complexes derived from the crystal structures in the Protein Data Bank revealed many cases of noncanonical S-O interactions involving the sulfur atom of methionine [32]. Most prominent were interactions with an ether oxygen atom in the ligand with a stereochemistry remarkably similar to the one observed for the Met127 ether oxygen interaction observed in the  PNPbGal-GAT complex. This opens the possibility that in acetyltransferases acting on di-and oligosaccharides, the structurally conserved methionine may coordinate the glycosidic bond and thereby fulfill an important role in proper positioning of the acceptor sugar within the active site.
So far, all members of the LbH family that have been crystallized share a catalytic histidine positioned in a loop protruding out of the LbH domain. Moreover, family members that use acetyl-CoA as donor substrate contain, in addition, a conserved tryptophan which is located opposite to the catalytic histidine but is contributed by the adjacent subunit [28,[33][34][35]. Previously, it was shown that His147 and Trp171 play a crucial role for NeuO activity [14]. The structural data show that both residues are located in the proposed active site in positions highly conserved among acetyltransferases of the LbH family (MAT [35], GAT [28], VatD [29], PaXAT [33], and OatWY [25]). On the basis of the structural data, the following catalytic mechanism can be proposed for NeuO ( Figure 6): (i) after binding of both substrates, His147 activates the hydroxyl group at position C-7 or C-9 of the Neu5Ac moiety currently positioned in the active site. This increases the nucleophilicity of the oxygen atom, thereby facilitating the attack of the thioester carbonyl of acetyl-CoA, (ii) resulting in the formation of a sialyl-acetyl-CoA intermediate. In this intermediate the thioester carbonyl adopts a tetragonal conformation with the carbonyl oxygen present as an oxyanion. (iii) In the final step of the reaction, His147 protonates the sulfur atom of CoA, releasing both substrates from the active site. Since the nucleophilic attack changes the hybridization state of the acetyl carbon from trigonal to tetragonal, it is difficult to unambiguously determine the residues that stabilize the intermediate oxyanion. It is conceivable that either the N e of Arg137 or Arg174 or the positive charge of Arg137 directly stabilizes the sialyl-CoA intermediate. A similar reaction mechanisms has been suggested for the serine acetyltransferases SAT of Haemophilus influenzae, and in this case, stabilization of the oxyanion by backbone amides was discussed [36].
Within the LbH-family, NeuO stands out with respect to its unique regulatory mechanism based on the variable N-terminal poly-y-domain formed by tandem copies of an RLKTQDS heptad. Due to slipped strand mispairing within the 59-VNTR region that encodes the poly-y-domain, a multitude of NeuO variants can be generated and so far, heptad numbers between 1 and 31 (corresponding to 3 to 93 nucleotide repeats) were observed in naturally occurring isolates [13]. Although the presence of the polyy-domain is not a prerequisite for NeuO activity, the catalytic efficiency increases linearly with the number of heptads [14]. To explain this effect, previous studies proposed a model in which the poly-y-domains of a functional trimer assemble into a triple coiledcoil [9,14]. However, the structural data do not confirm this model. Albeit the structure of the first 18 residues could not be solved for the apo-enzyme, the overall outline of NeuO with the N-termini of the three subunits pointing almost 65 Å away from each other, exclude the formation of a triple coiled-coil. Assuming the proposed extended mainly positively charged polySia binding site which involves N-terminally located residues such as Arg73 and Lys95, the N-terminal poly-y-domain might contribute to polySia binding by forming an extension of the acceptor binding site. Notably, each heptad contains two positively charged amino acids (Arg in position 1 and Lys in position 3 of the heptad), which could mediate interaction with the negatively charged carbohydrate polymer. In vitro, NeuO acts exclusively on sialic acid oligomers containing $14 residues [10,14], indicating that O-acetylation in vivo is a co-or postsynthetic process. The transfer of multiple acetyl groups per chain can be catalyzed either (i) by a processive mode with the growing polymer (which is elongated on the non-reducing end) gliding through the enzyme from the N-terminal binding site via the active site towards the positively charged platform or (ii) distributively by release of the polymer after each O-acetylation step followed by a new round of attachment and transfer. The flexible N-terminal poly-y-domain might facilitate the disentangling of the incoming polySia chains, gliding along the polymer and/or attachment to a new polymer chain, and thereby regulate NeuO activity.

Generation of constructs for phase-stable expression of NeuO
All constructs used in this study were based on pET22D, a modified pET22b vector (Novagen) in which the pelB leader sequence was removed by ligation of the oligonucleotides AKB42/AKB43 into the XbaI/BamHI sites of pET22b. pET22D-NeuO+0 carrying neuO without 59-VNTR-region was generated by subcloning of the BamHI/XhoI fragment of pET22Strep-NeuO+0 [14] into the corresponding sites of pET22D resulting in a plasmid which allows the expression of NeuO with a C-terminal hexahistidine tag. For phase-stable expression of the variant NeuO+12 comprising four Nterminal RLKTQDS heptads, the 12 tandem copies of the naturally occurring heptanucleotide sequence 59-AAGACTC-39 was replaced by an artificial sequence that still encoded four RLKTQDS heptads but lacked repetitive DNA elements. In the first step, the oligonucleotides AKB146/AKB147 encoding one heptad and comprising an AflII site were inserted into the BamHI site of pET22D-NeuO+0. The introduced second BamHI site was eliminated by fusion PCR using the primer pairs T7/AKB149 and pET-RP/ AKB148. Purified PCR-products were joined by PCR and the fragment was amplified by nested PCR with the primers T7 and AKB3. The resulting PCR-product was subcloned into the BamHI/ XhoI sites of pET22D. In a second step, the oligonucleotides AKB152/AKB153 encoding three RLKTQDS heptads were inserted by adapter ligation into the BamHI/AflII sites resulting in the plasmid pNeuO+12s. The identity of this construct was confirmed by sequencing. Sequences of all oligonucleotides are given in Table S1.

Expression and purification of NeuO+12
E. coli BL21 gold (DE3) (Novagen) transformed with pNeuO+12s were grown at 37uC in 2 L of Power Broth (AthenaES) containing 100 mg/ml carbenicillin. At an optical density (OD 600 ) of 1.8, expression was induced by adding 0.1 mM IPTG and bacteria were cultivated at 15uC for 20 h. Bacteria were harvested by centrifugation, lysed by sonication, and the soluble fraction was applied to a 5 ml HisTrap-chelating HP column (GE Healthcare). After washing with 25 ml of binding buffer (20 mM Tris-HCl pH 7.5, 500 mM NaCl, 40 mM imidazole), proteins were eluted with a linear imidazole gradient (40 to 500 mM imidazole in binding buffer). Enzyme-containing fractions were pooled and loaded immediately onto a HiLoad TM 16/60 Superdex TM 200 size-exclusion chromatography column (GE Healthcare) equilibrated with 10 mM Tris-HCl pH 7.5 and 150 mM NaCl at 4uC. NeuO-containing fractions were pooled, concentrated to 6.3 mg/ml by ultra filtration (Amicon Ultra-15 ultracel-10k, Millipore), aliquoted, and subsequently flash-frozen in liquid nitrogen.

Crystallization and data collection
Crystallization was performed at 20uC in sitting drop vapour diffusion plates. The protein was concentrated to a final concentration of 6.3 mg/ml and mixed with equal volumes of precipitant solution (0.1 M Tris pH 7.2; 0.45 M Glycine; 0.2 M NH 4 NO 3 ; 7% PEG4000 (w/v)). Crystals suitable for data collection experiments appeared randomly and scarcely after 1 week and grew to a final size of approximately 150 mm650 mm675 mm. Crystals were cryo-protected by soaking in a solution of mother-liquor containing 20% glycerol. Cryo-protected crystals were flash frozen in liquid nitrogen prior to data collection. Data collection was performed at 100 K at beamline 14.1 at Bessy Berlin.
Data processing, phasing and density modification X-ray diffraction data were indexed and integrated in the XDS suite [37,38] and scaled in ScalA [39]. Phases were obtained by molecular replacement in MOLREP [40] using a search model generated by homology modeling [41]. Initially a solution was found in a crystal that crystallized in space group P6 3 (data not shown). The partial model derived from this solution was subsequently used to phase the highest resolution datasets of the crystal form P2 1 . Model building was performed in Coot [42], density modification was performed in Parrot [39], refinement was performed in Phenix [43], and stereochemistry was analyzed in Rampage [39]. Molecular Images were generated in Pymol (DeLano Scientific).

PDB Accession code
Atomic coordinates and structure factors were deposited at the Research Collaboratory for Structural Bioinformatics (RCSB) Protein Databank (PDB) and are available under the accession number 3JQY.

Supporting Information
Table S1 Sequences of sense (s) and antisense (as) oligonucleotides. (DOCX) Figure S1 Stereochemistry Analysis of NeuO. All residues could be refined to good stereochemistry -no residues can be found in the disallowed region.